Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

NCT03139604 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT03139604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03139604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease
Lead sponsor
Incyte Corporation
Phase
Phase 3
Overall status
Completed
Start date
July 19, 2017
Completion date
July 13, 2020
Enrollment
439 (actual)
Sites
129

Conditions

As the registry lists them; a condition with its own page is linked.

graft-versus-host disease (gvhd)